PTPN22 and irritable bowel syndrome: In contrast to diabetes, the autoimmunity-associated polymorphic variant of the PTPN22 protein seems to be protective against IBD risk, an effect associated with alterations in the gut microbiota composition in humans (350) and mouse models of colitis (351).